,
your personalized virtual assistant to find clinical trials. Go head, 
John Byrd, MD
The Ohio State UniversityColumbus, Ohio - 43210 Ohio state UniversityColumbus, Ohio - 43210 Arthur G. James Cancer Hospital ...Columbus, Ohio - 43210-1240 Ohio State University Comprehensive Cancer ...Columbus, Ohio - 43210 |
- CLINICAL TRIALS 4
- CONDITIONS4
- INTERVENTIONS3
- SINCE2005
Safety and Tolerability of XmAb 5574 in Chronic Lymphocytic Leukemia
September 2010 - March 2012
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
July 2005 - March 2009
Multi-center Trial of Revlimid and Rituximab for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
February 2008 - July 2011
Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
April 2008 - March 2012
Lymphoma
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Plerixafor
Xmab®5574
Lenalidomide And Rituximab
